Trademark: 87083307
Word
PHARMABIDIOL
Status
Dead
Status Code
606
Status Date
Monday, February 19, 2018
Serial Number
87083307
Mark Type
4000
Filing Date
Friday, June 24, 2016
Published for Opposition
Tuesday, May 23, 2017
Abandoned Date
Monday, February 19, 2018

Trademark Owner History
Nic Quiles III - Owner At Publication

Classifications
5 Nutraceuticals for use as a dietary supplement; Nutraceuticals for use as a dietary supplement for treating inflammation, nausea, convulsions, cancer, anxiety, depression; Nutraceuticals for use as a dietary supplement for treating symptoms of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Nutraceuticals for use as a dietary supplement for treating symptoms of Crohns disease, multiple sclerosis, insomnia; Pharmaceutical agents affecting digestive organs; Pharmaceutical preparations for treating dandruff; Pharmaceutical preparations for treating diabetes; Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations, namely, antidepressants; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical products for skin care for animals; Pharmaceutical products for the prevention and treatment of cancer; Anti-epileptic pharmaceutical preparations; Dietary and nutritional supplements containing cannabis derivatives, namely, cannabidiol (CBD) oil; Dietary supplements also containing cannabis derivatives, namely, cannabidiol (CBD) oil; Digestives for pharmaceutical purposes; Medicated skin care preparations; Medicated oils containing cannabis derivatives, namely, cannabidiol (CBD) oil; Nutritional food additives for medical purposes in the nature of natural food extracts derived from cannabis, namely, cannabidiol (CBD) oil; Therapeutic pharmaceutical for the treatment of nicotine addiction, acne, diabetes, fibromyalgia, neurogenerative diseases, post-traumatic stress disorder; Therapeutic pharmaceutical for the treatment of inflammation, nausea, convulsions, cancer, anxiety, depression; Therapeutic pharmaceutical for the treatment of Crohns disease, multiple sclerosis, and insomnia

Trademark Events
Feb 20, 2018
Abandonment Notice Mailed - No Use Statement Filed
Feb 19, 2018
Abandonment - No Use Statement Filed
Jul 18, 2017
Noa E-Mailed - Sou Required From Applicant
May 23, 2017
Official Gazette Publication Confirmation E-Mailed
May 23, 2017
Published For Opposition
May 3, 2017
Notification Of Notice Of Publication E-Mailed
Apr 14, 2017
Approved For Pub - Principal Register
Apr 8, 2017
Teas/Email Correspondence Entered
Apr 7, 2017
Correspondence Received In Law Office
Apr 7, 2017
Teas Response To Office Action Received
Oct 17, 2016
Undeliverable Mail - Courtesy Copy Mailed
Oct 7, 2016
Notification Of Non-Final Action E-Mailed
Oct 7, 2016
Non-Final Action E-Mailed
Oct 7, 2016
Non-Final Action Written
Oct 4, 2016
Assigned To Examiner
Oct 1, 2016
Assigned To Examiner
Jun 29, 2016
New Application Office Supplied Data Entered In Tram
Jun 28, 2016
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24